 At 30 days after participants last dose of study drugs and then every 3 months - 1 month after that, a member of the study staff will contact participant by phone or at a regularly scheduled clinic visit to ask how participant is doing and about any side effects participant may have had. These calls or visits should last about 5-10 minutes each time. 